Baxter International Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Joe Almeida
Chief executive officer
US$13.8m
Total compensation
| CEO salary percentage | 9.4% |
| CEO tenure | 9yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.3yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?
Sep 05
Baxter- Reiterating Our Buy Rating After A Promising Q2
Aug 07Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29
Aug 07Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 23Baxter: Why Investors Should Take Advantage Of The Low Valuation
Jul 16Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues
Jul 12Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 30Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
May 14Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 08Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden
Jan 28Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12Dividend Challengers Review: Baxter International
Aug 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$121m |
| Jun 30 2024 | n/a | n/a | US$98m |
| Mar 31 2024 | n/a | n/a | -US$38m |
| Dec 31 2023 | US$14m | US$1m | -US$76m |
| Sep 30 2023 | n/a | n/a | US$96m |
| Jun 30 2023 | n/a | n/a | -US$3b |
| Mar 31 2023 | n/a | n/a | -US$3b |
| Dec 31 2022 | US$14m | US$1m | -US$3b |
| Sep 30 2022 | n/a | n/a | -US$3b |
| Jun 30 2022 | n/a | n/a | US$876m |
| Mar 31 2022 | n/a | n/a | US$992m |
| Dec 31 2021 | US$16m | US$1m | US$1b |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$1b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$16m | US$1m | US$1b |
| Sep 30 2020 | n/a | n/a | US$911m |
| Jun 30 2020 | n/a | n/a | US$924m |
| Mar 31 2020 | n/a | n/a | US$991m |
| Dec 31 2019 | US$14m | US$1m | US$1b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$16m | US$1m | US$2b |
Compensation vs Market: Joe's total compensation ($USD13.79M) is about average for companies of similar size in the US market ($USD12.51M).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
CEO
Joe Almeida (62 yo)
9yrs
Tenure
US$13,786,671
Compensation
Mr. Jose E. Almeida, also known as Joe, has been the Chairman of the Board and Chief Executive Officer of Baxter International Inc. since January 1, 2016 and serves as its President since January 01, 2016....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 9yrs | US$13.79m | 0.11% $ 17.6m | |
| Executive VP | 1.3yrs | US$5.37m | 0.0028% $ 438.2k | |
| Executive VP & Group President of Medical Products and Therapies | 1.8yrs | US$4.86m | 0.031% $ 4.9m | |
| Executive VP & Group President of Pharmaceuticals | 2.5yrs | US$3.87m | 0.0024% $ 373.3k | |
| Executive VP & Group President of Kidney Care | 1.6yrs | US$9.64m | 0.013% $ 2.0m | |
| Senior VP and Chief Medical & Scientific Officer | 2yrs | no data | no data | |
| Senior VP & Chief Information Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP & General Counsel | 2.8yrs | US$5.66m | 0.0018% $ 286.3k | |
| Senior Vice President | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 7.7yrs | US$4.14m | 0.037% $ 5.8m | |
| Executive VP & Chief Supply Chain Officer | 5yrs | no data | 0.0036% $ 567.9k |
2.3yrs
Average Tenure
54yo
Average Age
Experienced Management: BAX's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 9yrs | US$13.79m | 0.11% $ 17.6m | |
| Independent Director | 1.4yrs | US$197.82k | 0.0018% $ 281.6k | |
| Chairman Emeritus | 9yrs | US$17.88m | no data | |
| Independent Director | 7.9yrs | US$373.98k | 0.0055% $ 863.7k | |
| Independent Director | 5.9yrs | US$364.98k | 0.0042% $ 661.2k | |
| Independent Director | 3.1yrs | US$363.00k | 0.0028% $ 442.9k | |
| Independent Director | 8yrs | US$367.31k | 0.0044% $ 699.2k | |
| Lead Independent Director | 2.7yrs | US$382.31k | 0.0026% $ 411.3k | |
| Director | less than a year | no data | 0.00068% $ 107.6k | |
| Independent Director | 3.9yrs | US$357.00k | 0.0032% $ 504.6k | |
| Independent Director | 1.6yrs | US$226.35k | 0.0019% $ 305.3k | |
| Independent Director | 5.9yrs | US$352.98k | no data |
4.9yrs
Average Tenure
66yo
Average Age
Experienced Board: BAX's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 21:18 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Baxter International Inc. is covered by 44 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Benjamin Yeoh | Atlantic Equities LLP |
| Daniel Owczarski | Avondale Partners |